Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task
- PMID: 16043241
- DOI: 10.1016/j.bbr.2005.05.010
Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task
Abstract
Metabotropic glutamate receptors, including the mGlu1 receptor, have received considerable attention as potential targets for anxiolytic, antidepressant, antipsychotic and antinociceptive drugs. mGlu1 receptors have also been suggested to play a role in the modulation of cognitive processes, but knowledge is still very limited. In the present study the effects of the selective mGlu1 receptor antagonist 3,4-dihydro-2H-pyrano[2,3]beta-quinolin-7-yl)(cis-4-methoxycyclohexyl)methanone (JNJ16259685, 0.63-10 mg/kg s.c.) on more or less spatially demanding learning and spatial memory (retention and re-acquisition) were investigated in mice performing in a water maze. Selective mGlu1 receptor blockade with JNJ16259685 impaired spatial acquisition processes, irrespective of spatial load, as well as spatial re-acquisition, already at the lowest dose tested (0.63 mg/kg). In contrast, effects on spatial retention performance were relatively mild in mice that had learned to locate the position of the escape platform prior to treatment. Thigmotaxic behaviour and locomotor activity appeared to be unaffected by JNJ16259685. These data suggest that blockade of the mGlu1 receptor primarily affects learning of new information, but leaves retention of spatial information relatively unaffected. Blockade of the mGlu5 receptor with MPEP also impaired spatial learning, although only at the highest dose tested (10 mg/kg). An ex vivo receptor occupancy study in rats revealed that MPEP occupied central mGlu5 receptors with an ED(50) of 2.0 mg/kg one hour after subcutaneous administration. This is 50-150 times higher than the ED(50) reported for JNJ16259685 at central mGlu1 receptors and suggests that one reason why the two compounds cause cognitive effects at different doses might be due to differences in central mGlu receptor occupancy, rather than fundamentally different roles of mGlu1 and mGlu5 receptors in the modulation of cognitive function.
Similar articles
-
JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist.Neuropharmacology. 2004 Dec;47(7):961-72. doi: 10.1016/j.neuropharm.2004.08.007. Neuropharmacology. 2004. PMID: 15555631
-
The potent non-competitive mGlu1 receptor antagonist BAY 36-7620 differentially affects synaptic plasticity in area cornu ammonis 1 of rat hippocampal slices and impairs acquisition in the water maze task in mice.Neuroscience. 2008 Nov 19;157(2):385-95. doi: 10.1016/j.neuroscience.2008.08.063. Epub 2008 Sep 9. Neuroscience. 2008. PMID: 18832015
-
Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test.Psychopharmacology (Berl). 2005 Apr;179(1):198-206. doi: 10.1007/s00213-004-2056-7. Epub 2004 Dec 4. Psychopharmacology (Berl). 2005. PMID: 15821950
-
Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.J Cereb Blood Flow Metab. 2001 Sep;21(9):1013-33. doi: 10.1097/00004647-200109000-00001. J Cereb Blood Flow Metab. 2001. PMID: 11524608 Review.
-
Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.Eur J Pharmacol. 2010 Aug 10;639(1-3):2-16. doi: 10.1016/j.ejphar.2009.12.043. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371230 Review.
Cited by
-
Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.Psychopharmacology (Berl). 2013 Apr;226(3):541-50. doi: 10.1007/s00213-012-2925-4. Epub 2012 Nov 29. Psychopharmacology (Berl). 2013. PMID: 23192313
-
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.CNS Drug Rev. 2006 Summer;12(2):149-66. doi: 10.1111/j.1527-3458.2006.00149.x. CNS Drug Rev. 2006. PMID: 16958988 Free PMC article. Review.
-
Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats.Psychopharmacology (Berl). 2006 Sep;187(4):397-404. doi: 10.1007/s00213-006-0440-1. Epub 2006 Jun 20. Psychopharmacology (Berl). 2006. PMID: 16896963
-
mGlu5 Receptor Blockade Within the Nucleus Accumbens Shell Reduces Behavioral Indices of Alcohol Withdrawal-Induced Anxiety in Mice.Front Pharmacol. 2018 Nov 13;9:1306. doi: 10.3389/fphar.2018.01306. eCollection 2018. Front Pharmacol. 2018. PMID: 30483137 Free PMC article.
-
mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?Psychopharmacology (Berl). 2017 May;234(9-10):1333-1345. doi: 10.1007/s00213-017-4581-1. Epub 2017 Mar 11. Psychopharmacology (Berl). 2017. PMID: 28285325 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources